MedPath

Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsia

Not Applicable
Recruiting
Conditions
High risk pregnancy.
Supervision of high risk pregnancy
Registration Number
IRCT20151228025732N72
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Age 18 and above
Body mass index above 30
The interval between pregnancies is more than 10 years
Multiple pregnancy
Pre-gestational diabetes
Live singleton fetus

Exclusion Criteria

Heart, liver, thyroid diseases, history of asthma
Aspirin sensitivity
Threatened abortion such as vaginal bleeding
Eclampsia and pre-eclampsia at the time of study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vascular Resistance Index (RI). Timepoint: Before the intervention and 6 weeks after the intervention. Method of measurement: Color Doppler ultrasound.;Pulsatile index (PI). Timepoint: Before the intervention and 6 weeks after the intervention. Method of measurement: Color Doppler ultrasound.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath